Skip to main content

CalciMedica, Inc.

CALC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534133

No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding CalciMedica, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of CALC: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders31131+1
Shares3.57M51.1K3.68M+161.0K (+4.6%)
Value$10.9M$157.2K$24.2M+$13.5M (+124.7%)

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (7)

Institutions that held CalciMedica, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to CALC in Q4 2025
InstitutionSharesValue% of portfolio
Boothbay Fund Management, LLC76,855$506.5K0.01%
PVG Asset Management Corp45,830$302.0K0.64%
Timothy G. Youngquist 2020 Irrevocable Trust23,753$156.5K0.13%
Jane Street Group, LLC19,203$126.5K0.00%
TritonPoint Partners, LLC15,119$99.6K0.05%
Northern Trust Corp12,530$82.6K0.00%
Wells Fargo & Company10$660.00%

Sold out (6)

Institutions that held CalciMedica, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of CALC in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Tritonpoint Wealth, LLC15,119$46.5K
XTX Topco Ltd15,345$46.3K
Citigroup Inc4,927$15.2K
Morgan Stanley856$2.63K
Tower Research Capital LLC (TRC)666$2.05K
Barclays PLC57$175

Not filed for Q4 2025 yet (1)

Institutions that held CalciMedica, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CALC in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Sheets Smith Investment Management51,100$157.2K